Orqis Medical Corp.

By filling in gaps in the continuum of care, new technologies are shifting the management of heart failure from the palliation of a terminal illness to the management of a chronic disease. by Mary Stu

Orqis Medical Corp. slid in under the wire to present late-breaking clinical results for a landmark trial in congestive heart failure at the American College of Cardiology meeting in Chicago in Apri

Heart failure is a huge, growing market in which devices are looking to succeed where drugs have provided only limited benefit. Paracor’s strategy is to focus first on a mechanical approach in a field

Less might be more in heart failure, as new alternatives to left ventricular assist devices--less invasive, partial assist circulatory devices and percutaneous devices--promise to reach heart failure